Bioverativ Therapeutics is Biotechnology in United States that focus on biotechnology services business. Founded in 2016. They cover business area such as Provider, biotechnology service, various issue, wide range, chronic blood disorder, therapy, clinical trail, research, development, treatment method, cold agglutinin disease, sickle cell disease, beta thalassemia, medical institution, patient, scientific treatment, fatal blood disease.
2016
( 8 years old in 2024 )
Biotechnology Services
-
225 Second Avenue
Waltham, MA 02451
United States
Private
Providerbiotechnology servicevarious issuewide rangechronic blood disordertherapyclinical trailresearchdevelopmenttreatment methodcold agglutinin diseasesickle cell diseasebeta thalassemiamedical institutionpatientscientific treatmentfatal blood disease
* We use standard office opening hours in near Bioverativ Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Bioverativ Therapeutics is Biotechnology business from United States that founded in 2016 (8 years old in 2024), Bioverativ Therapeutics business is focusing on Biotechnology Services.
Bioverativ Therapeutics headquarter office and corporate office address is located in 225 Second Avenue Waltham, MA 02451 United States.
Bioverativ Therapeutics was founded in United States.
In 2024, Bioverativ Therapeutics is currently focus on biotechnology services sector.
Above is snippet of Google Trends for "biotechnology services" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Bioverativ Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
